Table of Contents
A Magazine for Alumni and Friends of Dartmouth Medical School and Dartmouth-Hitchcock Medical Center
Vol. 31, No. 2 Winter 2006
What if the way to win the war on cancer is not to cure tumors but to keep them from forming in the first place? Dartmouth's Michael Sporn, known as the "father of chemoprevention," has devoted his career to that question. Now he and his collaborators have two compounds in clinical trials—compounds that may stop tumors before they start.
If an influenza pandemic strikes again, it could be cold comfort to know that lessons learned from the 1918 flu epidemic may offer more help than modern medicine. Here are some insights gleaned from the Dartmouth archives and from a Dartmouth graduate who studies pandemics.
Dartmouth Medicine was spawned in 1976, when the dictum "Don't trust anyone over thirty" was still in vogue. In the three decades since then—through one name change, several redesigns, many production improvements, and, most significantly, countless changes in its subject matter—the magazine has endeavored to earn the trust of readers, to engage you in Dartmouth medicine.
February 16, 1998—as recorded in this lab notebook (check out the impeccable handwriting!)—was an auspicious day for a team of Dartmouth chemoprevention researchers. See "Compound Interest" for the associated feature. The cover photo is by Jon Gilbert Fox.
David Goodman, M.D.
Robert Michler, M.D., '81
If you'd like to offer feedback about Dartmouth Medicine, we'd welcome getting your comments at DartMed@Dartmouth.edu.